Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/173269
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Brunet, Joan | - |
dc.contributor.author | Darder, Esther | - |
dc.contributor.author | Valle Domínguez, Jesús del | - |
dc.contributor.author | Lázaro García, Conxi | - |
dc.contributor.author | ENIGMA Consortium | - |
dc.contributor.author | GENESIS Study Collaborators | - |
dc.contributor.author | SWE-BRCA Group | - |
dc.date.accessioned | 2021-01-20T08:23:46Z | - |
dc.date.available | 2021-01-20T08:23:46Z | - |
dc.date.issued | 2020-02-01 | - |
dc.identifier.uri | http://hdl.handle.net/2445/173269 | - |
dc.description.abstract | Germline protein truncating variants (PTVs) in the FANCM gene have been associated with a 2-4-fold increased breast cancer risk in case-control studies conducted in different European populations. However, the distribution and the frequency of FANCM PTVs in Europe have never been investigated. In the present study, we collected the data of 114 European female breast cancer cases with FANCM PTVs ascertained in 20 centers from 13 European countries. We identified 27 different FANCM PTVs. The p.Gln1701* PTV is the most common PTV in Northern Europe with a maximum frequency in Finland and a lower relative frequency in Southern Europe. On the contrary, p.Arg1931* seems to be the most common PTV in Southern Europe. We also showed that p.Arg658*, the third most common PTV, is more frequent in Central Europe, and p.Gln498Thrfs*7 is probably a founder variant from Lithuania. Of the 23 rare or unique FANCM PTVs, 15 have not been previously reported. We provide here the initial spectrum of FANCM PTVs in European breast cancer cases. | - |
dc.format.extent | 10 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/cancers12020292 | - |
dc.relation.ispartof | Cancers, 2020, vol. 12, num. 2 | - |
dc.relation.uri | https://doi.org/10.3390/cancers12020292 | - |
dc.rights | cc by (c) Figlioli et al., 2020 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | - |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | Càncer de mama | - |
dc.subject.classification | Factors de risc en les malalties | - |
dc.subject.other | Breast cancer | - |
dc.subject.other | Risk factors in diseases | - |
dc.title | The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2020-12-21T13:15:27Z | - |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/634935/EU//BRIDGES | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 31991861 | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FiglioliG.pdf | 1.2 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License